Instrument Inactif

Communiqués Boule Diagnostics AB Nasdaq Stockholm

Actions

Bulletin from the Annual General Meeting May 8, 2024 in Boule Diagnostics AB	08/05	AQ
Boule Diagnostics : interim report Q4 2022	02/02/23	PU
Boule Diagnostics : Partnership for free diagnostic services	22/08/22	PU
Boule Diagnostics : The utility of CBC results in initial fever investigations	19/07/22	PU
Boule Diagnostics : Q2 2022 presentation.	18/07/22	PU
Boule Diagnostics : Q2 2022 presentation	18/07/22	PU
Boule Diagnostics : appoints David Metrena to lead US commercial organization	03/06/22	PU
Boule Diagnostics : Reducing turnaround time (TAT) of test results with Swelab	30/05/22	PU
Boule Diagnostics : Reducing turnaround time (TAT) of test results with Swelab Alfa Plus	30/05/22	PU
Boule Diagnostics : Annual report 2021	27/04/22	PU
Boule Diagnostics : profile interview – Dr. Charles Adeogun	19/04/22	PU
Boule Diagnostics : Understanding blood cell histograms	17/03/22	PU
Boule Diagnostics : What you need to know about complete blood counts from capillary samples	18/02/22	PU
Boule Diagnostics : What you need to know about CBC testing from capillary blood	18/02/22	PU
Boule Diagnostics : Q4 presentation	03/02/22	PU
Boule Diagnostics AB Q3 presentation	10/11/21	PU
Boule Diagnostics : Nomination Committee for the AGM 2022	22/10/21	PU
Boule Diagnostics : Q2 presentation	19/07/21	PU
Boule Diagnostics (publ) : Interim report January–September 2019	30/10/19	PU

Aucun résultat pour cette recherche